Skip to main content

Advertisement

SpringerLink
Log in

Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a Systematic Review and Meta-analysis

  • Original Article
  • Published:
The Cerebellum Aims and scope Submit manuscript

Abstract

The objective of this study is to synthesise the findings of clinical studies in order to derive evidence for use of the mesenchymal stem cell (MSC) therapy in the treatment of neurodegenerative cerebellar ataxias. In order to find relevant studies for the systematic review, we searched through Medline (1985 to July 2020), PubMed and Clinical trial register. We included both single-arm and comparative studies in which MSCs were given as intervention in neurodegenerative ataxia patients at any time after the diagnosis. We used Joanna Briggs Institute (JBI) quality scale to evaluate the methodological qualities of the included studies. Our literature search obtained 81 publications. Three articles comprising a total of 47 patients were included in the meta-analysis. None of them were randomised controlled trials (RCTs). Pooled analysis noted that there was a decrease in the Berg Balance Scale (BBS)/Scale for the Assessment and Rating of Ataxia (SARA) score from pre to post assessment; however, the difference was statistically not significant (standardised mean difference (SMD) − 0.20; 95% CI − 0.78 to 0.38). No significant side effects were reported in any of the studies. We did not observe any statistically significant difference in the pooled mean difference in the International Cooperative Ataxia Rating Scale (ICARS) score between pre and post assessment in patients with ataxia after receiving the stem cells (SMD 0.36, 95% CI − 0.08 to 0.81). Our systematic review and meta-analysis concluded that MSC cell therapy appeared safe but provided insufficient evidence to support the use of MSCs to treat patients with neurodegenerative cerebellar ataxia at present. No l RCTs was available in the literature to test efficacy; therefore, well-designed RCTs are needed to ascertain the effectiveness of MSCs in patients with neurodegenerative cerebellar ataxias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

BBS:

Berg Balance Scale

ICARS:

International Cooperative Ataxia Rating Scale

SARA:

Scale for the Assessment and Rating of Ataxia

SMD:

Standardised mean difference

References

  1. Ashizawa T, Xia G. Ataxia. Contin Lifelong Learn Neurol. 2016;22:1208–26.

    Article  Google Scholar 

  2. Yabe I. Sasaki H [Advances in neurological therapeutics for Friedreich ataxia and Machado-Joseph disease]. Brain Nerve Shinkei Kenkyu No Shinpo. 2017;69:913–24.

    CAS  PubMed  Google Scholar 

  3. Kearney M, Orrell RW, Fahey M, Brassington R, Pandolfo M. Pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev [Internet]. 2016 [cited 2019 Sep 20]; Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007791.pub4/full?highlightAbstract=ataxia%7Cwithdrawn%7Cataxi

  4. Vogel AP, Folker J, Poole ML. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes. Cochrane Database Syst Rev [Internet]. 2014 [cited 2019 Sep 20]; Available from: https://www.cochranelibrary.com/cdsr/doi/https://doi.org/10.1002/14651858.CD008953.pub2/full?highlightAbstract=withdrawn%7Cataxi%7Cataxia%7Cspinocerebellar

  5. Koller WC. Pharmacologic trials in the treatment of cerebellar tremor. Neurology [Internet]. 33 Suppl 2 [cited 2020 Jan 6]; Available from: https://www.cochranelibrary.com/central/doi/https://doi.org/10.1002/central/CN-00446139/full

  6. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004;8:301–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Duncan T, Valenzuela M. Alzheimer’s disease, dementia, and stem cell therapy. Stem Cell Res Ther [Internet]. 2017 [cited 2020 Jan 6];8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427593/

  8. Zeng L, Chan LL, Lim EC, Tan EK. Stem cell replacement therapies in Parkinson’s disease. 2019;48:3

  9. Aliaghaei A, Boroujeni ME, Ahmadi H, Bayat A-H, Tavirani MR, Abdollahifar MA, et al. Dental pulp stem cell transplantation ameliorates motor function and prevents cerebellar atrophy in rat model of cerebellar ataxia. Cell Tissue Res. 2019;376:179–87.

    Article  PubMed  Google Scholar 

  10. Chintawar S, Hourez R, Ravella A, Gall D, Orduz D, Rai M, et al. Grafting neural precursor cells promotes functional recovery in an SCA1 mouse model. J Neurosci. 2009;29:13126–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lukovic D, Moreno-Manzano V, Rodriguez-Jimenez FJ, Vilches A, Sykova E, Jendelova P, et al. hiPSC disease modeling of rare hereditary cerebellar ataxias: opportunities and future challenges. Neuroscientist. 2017;23:554–66.

    Article  CAS  PubMed  Google Scholar 

  12. Jones J, Jaramillo-Merchán J, Bueno C, Pastor D, Viso-León M, Martínez S. Mesenchymal stem cells rescue Purkinje cells and improve motor functions in a mouse model of cerebellar ataxia. Neurobiol Dis. 2010;40:415–23.

    Article  PubMed  Google Scholar 

  13. Chang Y-K, Chen M-H, Chiang Y-H, Chen Y-F, Ma W-H, Tseng C-Y, et al. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells. J Biomed Sci. 2011;18:54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Arien-Zakay H, Lecht S, Bercu MM, Tabakman R, Kohen R, Galski H, et al. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp Neurol. 2009;216:83–94.

    Article  CAS  PubMed  Google Scholar 

  15. Dongmei H, Jing L, Mei X, Ling Z, Hongmin Y, Zhidong W, et al. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy. 2011;13:913–7.

    Article  PubMed  Google Scholar 

  16. Jin J-L, Liu Z, Lu Z-J, Guan D-N, Wang C, Chen Z-B, et al. Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia [Internet]. 2013 [cited 2020 Jan 6]. Available from: https://www.ingentaconnect.com/content/ben/cnr/2013/00000010/00000001/art00003

  17. Tsai Y-A, Liu R-S, Lirng J-F, Yang B-H, Chang C-H, Wang Y-C, et al. Treatment of spinocerebellar ataxia with mesenchymal stem cells: a phase I/IIa clinical study. Cell Transplant. 2017;26:503–12.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Yang W-Z, Zhang Y, Wu F, Zhang M, Cho S, Li C-Z, et al. Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with hereditary ataxia. J Transl Med. 2011;9:65.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7:7.

    PubMed  PubMed Central  Google Scholar 

  20. Appelt PA, Comella K, de Souza LAPS, Luvizutto GJ. Effect of stem cell treatment on functional recovery of spinocerebellar ataxia: systematic review and meta-analysis. Cerebellum Ataxias. 2021;8:8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Manish Bhartiya and Amit Kumar contributed equally to this work.

Authors and Affiliations

  1. Department of Neurology, CN Centre, All India Institute of Medical Sciences, Room No. 60 GF, New Delhi, 110029, India

    Manish Bhartiya, Amit Kumar, Rakesh K. Singh, Divya M Radhakrishnan, Roopa Rajan & Achal Kumar Srivastava

Authors
  1. Manish Bhartiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amit Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rakesh K. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Divya M Radhakrishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roopa Rajan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Achal Kumar Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Achal Kumar Srivastava.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhartiya, M., Kumar, A., Singh, R.K. et al. Mesenchymal Stem Cell Therapy in the Treatment of Neurodegenerative Cerebellar Ataxias: a Systematic Review and Meta-analysis. Cerebellum 22, 363–369 (2023). https://doi.org/10.1007/s12311-022-01403-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12311-022-01403-6

Keywords

Search

Navigation